Skip main navigation

Introduction to Aminoglycosides

An introduction to aminoglycosides including their history and use. In this article, Naomi covers important details on the antibiotic class.
Series of speech bubbles that contain question marks and a lightbulb.
The commonly prescribed antibiotics in the aminoglycoside group include:

  • Gentamicin
  • Amikacin
  • Tobramycin
  • Neomycin

These aminoglycosides are not absorbed from the gut (although there is a risk of absorption in inflammatory bowel disease and liver failure), so need to be given by injection for systemic infections.

When used intravenously, serum concentration monitoring avoids both excess and subtherapeutic concentrations, preventing toxicity and ensuring efficacy. Adverse effects (e.g. nephrotoxicity and ototoxicity), associated with levels in the blood being too high, are particularly likely in: the elderly, obese, cystic fibrosis, situations where high doses are being given and renal impairment.

Care must be taken with dosage as the main side-effects of the aminoglycosides are dose-related. Aminoglycosides should be avoided in myasthenia gravis and caution used in conditions characterised by muscular weakness, as aminoglycosides may impair neuromuscular transmission. If possible, dehydration should be corrected before starting an aminoglycoside and whenever possible, parenteral treatment should not exceed 7 days.

© BSAC
This article is from the free online

Optimise Aminoglycoside Use in Clinical Practice

Created by
FutureLearn - Learning For Life